TFE3 fusions direct an oncogenic transcriptional program that drives OXPHOS and unveils vulnerabilities in translocation renal cell carcinoma
Jiao Li(Harvard University), Srinivas R. Viswanathan(Broad Institute)
Cited by 6
Related Papers
The mTOR kinase inhibitor everolimus synergistically enhances the anti‐tumor effect of the Bruton's tyrosine kinase (BTK) inhibitor PLS‐123 on Mantle cell lymphoma
|International Journal of Cancer|2017|29
Neuroprotective effects of leonurine against oxygen–glucose deprivation by targeting Cx36/CaMKII in PC12 cells
|PLoS ONE|2018|17
Phenotypic screening converges on CDK9 inhibition as a therapeutic strategy in translocation renal cell carcinoma
|bioRxiv (Cold Spring Harbor Laboratory)|2025|1